Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

Degirolamo, Chiara, Sabbà, Carlo, Moschetta, Antonio·2016·Nature Reviews Drug Discovery

Cites (240)

Items 201–239 of 239

  1. Diet1 Functions in the FGF15/19 Enterohepatic Signaling Axis to Modulate Bile Acid and Lipid Levels
    Laurent Vergnes, Jessica M. Lee, Robert G. Chin, Johan H. Auwerx, Karen Reue · 2013 · Cell Metabolism
  2. Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice
    Wing Yan So, Qi Cheng, Aimin Xu, Karen S.L. Lam, Po Sing Leung · 2015 · Cell Death and Disease
  3. Antibody-Mediated Inhibition of Fibroblast Growth Factor 19 Results in Increased Bile Acids Synthesis and Ileal Malabsorption of Bile Acids in Cynomolgus Monkeys
    Rama Pai, Dorothy M. French, Ning Ma, Kathy Hötzel, Emile G. Plise, Laurent Salphati, Kenneth D.R. Setchell, Joseph A. Ware, Veronique Lauriault, Leah Schutt et al. · 2012 · Toxicological Sciences
  4. Stressed Liver and Muscle Call on Adipocytes with FGF21
    Yongde Luo, Wallace L. McKeehan · 2013 · Frontiers in Endocrinology
  5. Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones
    Andrew Charles Adams, Tamer Coşkun, Christine Cheng, Libbey S. O’Farrell, Susan L. DuBois, Alexei Kharitonenkov · 2013 · Molecular Metabolism
  6. Plasma FGF21 displays a circadian rhythm during a 72‐h fast in healthy female volunteers
    Birgitte Andersen, Henning Beck‐Nielsen, Kurt Højlund · 2011 · Clinical Endocrinology
  7. Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome
    Jun Zhang, Yang Li · 2013 · Drug Discovery Today
  8. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta)
    Else Nygaard, Cathrine Laustrup Møller, Paul Kievit, Kevin L. Grove, B Andersen · 2013 · International Journal of Obesity
  9. Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice
    Yan Weng, J Chabot, Barbara L. Bernardo, Qingyun Yan, Yimin Zhu, Martin B. Brenner, Chandra Vage, Alison Logan, Roberto A. Calle, Saswata Talukdar · 2015 · PLoS ONE
  10. Increased parathyroid expression of klotho in uremic rats
    Jacob Hofman-Bang, Giedre Martus, Martin A. Santini, Klaus Ølgaard, Ewa Lewin · 2010 · Kidney International
  11. Antibody-Mediated Activation of FGFR1 Induces FGF23 Production and Hypophosphatemia
    Ai-Luen Wu, Bo Feng, Mark Z. Chen, Ganesh A. Kolumam, Jose Zavala‐Solorio, Shelby K. Wyatt, Vineela D. Gandham, Richard A.D. Carano, Junichiro Sonoda · 2013 · PLoS ONE
  12. A chronic high-cholesterol diet paradoxically suppresses hepatic CYP7A1 expression in FVB/NJ mice
    Anne S. Henkel, Kristy A. Anderson, Amanda M. Dewey, Mark H. Kavesh, Richard M. Green · 2010 · Journal of Lipid Research
  13. Metformin Stimulates FGF21 Expression in Primary Hepatocytes
    Eva B. Nygaard, Sara G. Vienberg, Cathrine Ørskov, Harald Severin Hansen, Birgitte Andersen · 2012 · Experimental Diabetes Research
  14. Polyethylene Glycol Modified FGF21 Engineered to Maximize Potency and Minimize Vacuole Formation
    Jing Xu, Jeanine L. Bussiere, Junming Yie, E. Allen Sickmier, Phil An, Ed Belouski, Shanaka Stanislaus, Kenneth W. Walker · 2013 · Bioconjugate Chemistry
  15. FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/β-Klotho Bispecific Protein
    Richard J. Smith, Amy N. Duguay, Alice Bakker, Peng Li, Jennifer Weiszmann, Melissa R. Thomas, Benjamin M. Alba, Xinle Wu, Jamila Gupte, Yang Li et al. · 2013 · PLoS ONE
  16. Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR
    Wolfgang Wistuba · 2007 · World Journal of Gastroenterology
  17. Fibroblast Growth Factor Receptor 4 (FGFR4) Deficiency Improves Insulin Resistance and Glucose Metabolism under Diet-induced Obesity Conditions
    Hongfei Ge, Jun Zhang, Yan Gong, Jamila Gupte, Jay Ye, Jennifer Weiszmann, Kim Samayoa, Suzanne K. Coberly, Jonitha Gardner, Huilan Wang et al. · 2014 · Journal of Biological Chemistry
  18. Evolutionary conservation of CCND1-ORAOV1-FGF19-FGF4 locus from zebrafish to human
    Masuko Katoh, Masaru Katoh · 2003 · International Journal of Molecular Medicine
  19. Regulation of Amphiregulin Gene Expression by β-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System
    Maria Ujue Latasa, Fabiana Salis, Raquel Urtasun, Oihane García‐Irigoyen, María Elizalde, Iker Uriarte, Mónica Santamaría, Francesco Feo, Rosa M. Pascale, Jesús Prìeto et al. · 2012 · PLoS ONE
  20. Detection of FGF15 in Plasma by Stable Isotope Standards and Capture by Anti-peptide Antibodies and Targeted Mass Spectrometry
    Takeshi Katafuchi, Daria Esterházy, Andrew S. Lemoff, Xunshan Ding, Varun Sondhi, Steven A. Kliewer, Hamid Mirzaei, David J. Mangelsdorf · 2015 · Cell Metabolism
  21. A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol
    Zhifeng Huang, Huiyan Wang, Meifei Lu, Chuanchuan Sun, Xiaoping Wu, Yi Tan, Chaohui Ye, Guanghui Zhu, Xiaojie Wang, Lu Cai et al. · 2011 · PLoS ONE
  22. Fibroblast Growth Factor 19 Serum Levels: Relation to Renal Function and Metabolic Parameters
    M. Reiche, Anette Bachmann, Ulrike Lössner, Matthias Blüher, Michael Stümvoll, Mathias Faßhauer · 2009 · Hormone and Metabolic Research
  23. 'Dem bones' are made for more than walking
    L. Darryl Quarles · 2011 · Nature Medicine
  24. Time-imposed daily restricted feeding induces rhythmic expression of Fgf21 in white adipose tissue of mice
    Katsutaka Oishi, Morichika Konishi, Yusuke Murata, Nobuyuki Itoh · 2011 · Biochemical and Biophysical Research Communications
  25. Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19
    Masaaki Miyata, Tatsuya Hata, Hiroki Yamakawa, Tatehiro Kagawa, Kouichi Yoshinari, Yasushi Yamazoe · 2012 · The Journal of Steroid Biochemistry and Molecular Biology
  26. Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice
    Raul C. Camacho, Peter Zafian, Joana Achanfuo-Yeboah, Anthony Manibusan, Joel P. Berger · 2013 · European Journal of Pharmacology
  27. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion
    Hillel Galitzer, Iddo Z. Ben‐Dov, Vardit Lavi-Moshayoff, Tally Naveh‐Many, Justin Silver · 2008 · Current Opinion in Nephrology & Hypertension
  28. SREBP-2 negatively regulates FXR-dependent transcription of FGF19 in human intestinal cells
    Masaaki Miyata, Tatsuya Hata, Yasushi Yamazoe, Kouichi Yoshinari · 2013 · Biochemical and Biophysical Research Communications
  29. A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog
    Lintao Song, Yanlin Zhu, Huiyan Wang, Artur A. Belov, Jianlou Niu, Lu Shi, Yaoyao Xie, Chaohui Ye, Xiaokun Li, Zhifeng Huang · 2014 · Biomaterials
  30. Regulation of bile acid synthesis under reconstructed enterohepatic circulation in rats
    Masahiro Nagano, Syoji Kuroki, Atsushi Mizuta, Masae Furukawa, Mitsuhide Noshiro, Kazuo Chijiiwa, Masao Tanaka · 2004 · Steroids
  31. FGF19 (fibroblast growth factor 19) as a novel target gene for activating transcription factor 4 in response to endoplasmic reticulum stress
    Makoto Shimizu, Juan Li, Ryuto Maruyama, Jun Inoue, Ryuichiro Sato · 2012 · Biochemical Journal
  32. Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice
    Xing Xian Yu, Lynnetta M. Watts, Vara Prasad Manchem, Kaushik Chakravarty, Brett P. Monia, Michael L. McCaleb, Sanjay Bhanot · 2013 · PLoS ONE
  33. Thiazolidinediones Are Potent Inducers of Fibroblast Growth Factor 21 Expression in the Liver
    Katsutaka Oishi, Tatsunosuke Tomita · 2011 · Biological and Pharmaceutical Bulletin
  34. Mechanistic Investigation of the Preclinical Pharmacokinetics and Interspecies Scaling of PF-05231023, a Fibroblast Growth Factor 21–Antibody Protein Conjugate
    Craig Giragossian, Chandra Vage, Jun Li, Kathleen B. Pelletier, Nicole Piche‐Nicholas, Manoj Rajadhyaksha, Jennifer L. Liras, Alison Logan, Roberto A. Calle, Yan Weng · 2015 · Drug Metabolism and Disposition
  35. Various Oscillation Patterns of Serum Fibroblast Growth Factor 21 Concentrations in Healthy Volunteers
    Sang Ah Lee, Eunheiu Jeong, Eun Hee Kim, Mi‐Seon Shin, Jenie Yoonoo Hwang, Eun Hee Koh, Woo Je Lee, Joong‐Yeol Park, Min‐Seon Kim · 2012 · Diabetes & Metabolism Journal
  36. Hepatocyte FRS2α is Essential for the Endocrine Fibroblast Growth Factor to Limit the Amplitude of Bile Acid Production Induced by Prandial Activity
    Cheng Wang, Chuen‐Mao Yang, Julia Yu‐Fong Chang, Pan You, Y. Li, Chengliu Jin, Yongde Luo, X. Li, Wallace L. McKeehan, Fei Wang · 2014 · Current Molecular Medicine
  37. The Sum of All Browning in FGF21 Therapeutics
    Paul Lee, Michael M. Swarbrick, Jerry Richard Greenfield · 2015 · Cell Metabolism
  38. Klotho spins the thread of life--what does Klotho do to the receptors of fibroblast growth factor-23 (FGF23)?
    Tilman Bernhard Drüeke, Dominique Prié · 2007 · Nephrology Dialysis Transplantation
  39. Biologists abandon Popper at their peril
    2000